- Forbes•9 hours ago
Samsung Electronics published a tough set of Q3 2016 results, posting year-over-year declines in revenues (down 7% to $41.9 billion) and operating profits (down 30% to $4.6 billion), as the impact of the recall and discontinuation of the flagship Galaxy Note 7 handset more than offset gains at the firm’s
- The Wall Street Journal•12 hours ago
Samsung Group’s contract drug-manufacturing arm is on track to raise $1.96 billion early next month, in what would be one of the world’s largest listings this year.
The numbers are now in for smartphone sales, following Apple’s (AAPL) fiscal Q4 report on Tuesday, and Samsung Electronics’s (005930KS) Q3 report overnight, and the commentary for both companies is not that great relative to challengers such as Oppo and Huawei. Research firm Strategy Analytics reports this morning that global shipments “recovered” in Q3, rising 6%, year over year, to 375 million units. Samsung held top spot with 75.3 million units, at 20%, down from its 23% share a year earlier, with a 10% decline in unit shipments, a direct result of the disaster with its “Note 7” smartphone.
Samsung Electronics Co. Ltd. (005930.KS)
KSE - KSE Delayed Price. Currency in KRW
|Day's Range||1,580,000.00 - 1,614,000.00|
|52wk Range||1,088,000.00 - 1,716,000.00|
|1y Target Est||N/A|
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||260,920|
|Dividend & Yield||N/A (N/A)|